362 related articles for article (PubMed ID: 27342486)
1. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
[No Abstract] [Full Text] [Related]
3. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
4. [Improved clinical outcome of acute myeloid leukemia with FLT3-ITD mutation treated with sorafenib].
Gu B; Chen GH; Shen HJ; Ma X; Fu CC; Han Y; Tang XW; Miao M; Qiu HY; Sun AN; Wu DP
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):293-7. PubMed ID: 27030618
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic Significance of CD45
Sun Q; Zhang HX; Hu CY; Han YH; Bu XT; Li HJ; Li ZY; Yan ZL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):702-707. PubMed ID: 31204919
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].
Zhou JR; Zhang X; Zhao YL; Yang JF; Zhang JP; Cao XY; Lu Y; Liu DY; Lyu FY; Ouyang J; Lu PH
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):751-756. PubMed ID: 30369187
[No Abstract] [Full Text] [Related]
7. [Clinical Efficacy of NOPHO-AML 2004 Regimen for Treatment of Children with Acute Myelocytic Leukemia (Non-M3)].
Qiu KY; Liao XY; Huang K; Li Y; Weng WJ; Xu HG; Fang JP; Wu RH; Zhou DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):375-381. PubMed ID: 29665901
[TBL] [Abstract][Full Text] [Related]
8. [Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia].
Qin T; Xu Z; Zhang Y; Lin Y; Ru K; Fang L; Zhang H; Pan L; Hu N; Qu S; Wang J; Xing R; Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):94-9. PubMed ID: 27014976
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL].
Li J; Zhang ZB; Liu ZR; Yang M; Nie YX; Wu MM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1011-1015. PubMed ID: 30111399
[TBL] [Abstract][Full Text] [Related]
10. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.
Muto T; Takeuchi M; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Aotsuka N; Iseki T; Nakaseko C
Int J Hematol; 2015 Jul; 102(1):86-92. PubMed ID: 25758097
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of
Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic Analysis of Minimal Residual Disease from Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplant by Flow Cytometry].
Hao Q; Zhang SQ; Zhang DM; Wang JB; Zhao J; Cheng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):239-244. PubMed ID: 29397851
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of clinical outcomes of 63 children with acute monocytic leukemia].
Xu YY; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Ye QD; Luo CY; Zhou M; Gu LJ
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):175-80. PubMed ID: 21575364
[TBL] [Abstract][Full Text] [Related]
20. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
